A Phase 1, Open-Label Study to Assess Psychological and Biological Effects of MDMA Assisted Therapy When Administered to Mental Health Providers in Training to be MDMA-Assisted Therapists
This is a phase 1, open-label study to assess changes in mental well-being following MDMA administration within a therapeutic setting, in mental health providers who are in training to become MDMA assisted therapists. Secondary outcome measures will examine the effects on provider burnout, provider self-efficacy, mood, self-compassion, quality of life, and other psychological factors. Participants will work with a co-therapy pair as they engage in a preparatory session, one experimental session with MDMA, and an integration session the following day.
- Status
- recruiting
- Phase
- Phase 1
- Institution
- Rachel Yehuda
- Principal investigator
- Tamar Glatman Zaretsky
- Start date
- 2026-02-11
- End date
- 2029-12-21
- Registry ID
- NCT07102576
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.